Arthrogryposis-renal Dysfunction-cholestasis Syndrome

Document Type : Case Report

Authors

Department of Pediatrics, Tehran University of Medical Sciences, Tehran, Iran

Abstract

Background: Arthrogryposis-renal dysfunction-cholestasis (ARC) syndrome is a rare autosomal recessive disorder mostly affecting the liver, kidney, skin, as well as central nervous and musculoskeletal systems. This multisystemic disease results from mutations in the vacuolar protein sorting 33B (VPS33B) or VPS33B- interacting protein, and apical-basolateral polarity regulator (VIPAR) genes. This is a lethal disorder from which few patients can survive at the first year of their life. This syndrome exhibits a wide range of phenotypes, such as ichthyosis, hypothyroidism, agenesis of the corpus callosum, and congenital cardiovascular anomalies.
Case report: Here, we present the case of a 32-day-old male neonate with respiratory distress admitted to Children's Medical Center Hospital in Tehran, Iran, in August 2019. He had ichthyosis, cholestasis with arthrogryposis as bilateral clubfeet, developmental dysplasia of the hip, and flexion contractures in upper limbs. During hospitalization, he received Shohl’s solution for metabolic acidosis, intravenous antibiotics, fat-soluble vitamins, and levothyroxine. Other  presentations in our case included  ichthyosis, failure to thrive, congenital heart disease, and hypothyroidism.
Conclusion: Timely diagnosis, supportive care and genetic counseling should be provided for better outcome.
 
Keywords: 

Keywords

References

  1. Lee MJ, Suh CR, Shin JH, Lee JH, Lee Y, Eun BL, et al. A novel VPS33B variant identified by exome sequencing in a patient with arthrogryposis-renal dysfunction-cholestasis syndrome. Pediatr Gastroe-nterol Hepatol Nutr. 2019; 22(6):581-7.
  2. Akbar MA, Mandraju R, Tracy C, Hu W, Pasare C, Krämer H. ARC syndrome-linked Vps33B protein is required for inflammatory endosomal maturation and signal termination. Immunity. 2016; 45(2):
    267-79.
  3. Moon AT, Christensen T, Streicher JL, Castelo‐Soccio L. A novel VPS 33B mutation in a patient with arthrogryposis‐renal dysfunction‐cholestasis synd-rome. Pediatr Dermatol. 2017; 34(4):e171-3.
  4. Chai M, Su L, Hao X, Zhang M, Zheng L, Bi J, et al. Identification of genes and signaling pathways associated with arthrogryposis‑renal dysfunction‑ cholestasis syndrome using weighted correlation network analysis. Int J Mol Med. 2018; 42(4):
    2238-46.
  5. Malaki M, Mandana R, Ghaffari S. ARC syndrome with complex renal problems: nephrocalcinosis, proximal and hyperkalemic distal RTA and nephrogenic diabetes insipidus. Saudi J Kidney Dis Transpl. 2012; 23(4):804-9.
  6. Duong MD, Rose CM, Reidy KJ, Del Rio M.
    An uncommon case of arthrogryposis, renal dysfunction, and cholestasis (ARC) syndrome and review of the renal involvement: answers. Pediatr Nephrol. 2020; 35(2):249-51.
  7. Rosales A, Mhibik M, Gissen P, Segarra O, Redecillas S, Ariceta G. Severe renal fanconi and management strategies in arthrogryposis-renal dysfunction-cholestasis syndrome: a case report. BMC Nephrol. 2018; 19(1):144.
  8. Chen CH, Lo RW, Urban D, Pluthero FG, Kahr WH. α-granule biogenesis: from disease to discovery. Platelets. 2017; 28(2):147-54.
  9. Giraud A, Ramond F, Cremillieux C, Touraine R, Patural H, Stephan J. The complex phenotype of ARC syndrome: a new case. Arch Pediatr. 2017; 24(2):131-4.

10. Aflatounian M, Smith H, Farahani F, Naeem AT, Straatman-Iwanowska A, Zoghi S, et al. Novel VIPAS39 mutation in a syndromic patient with arthrogryposis, renal tubular dysfunction and intrahepatic cholestasis. Eur J Med Genet. 2016; 59(4):237-9.

11. Zhou Y, Zhang J. Arthrogryposis–renal dysfunction–cholestasis (ARC) syndrome: from molecular genetics to clinical features. Ital J Pediatr. 2014; 40(1):77.

12. Agawu A, Sheppard S, Lin HC. A novel VPS33B mutation causing a mild phenotype of arthrogryposis, renal dysfunction, and cholestasis syndrome. J Pediatr Gastroenterol Nutr. 2019; 69(2):e55-6.

13. Huang D, Liu J, Guo L, Song Y. Clinical features and VPS33B mutations in a family affected by arthrogryposis, renal dysfunction, and cholestasis syndrome. Zhongguo Dang Dai Er Ke Za Zhi. 2017; 19(10):1077-82.

14. Gupra V, Pandita A, Panghal A, Kallem V. Arthrogryposis, renal dysfunction and cholestasis (ARC) syndrome: a rare association with high GGT level and absent kidney. BMJ Case Rep. 2018; 2018:bcr2017223715.

15. Rogerson C, Gissen P. VPS33B and VIPAR are essential for epidermal lamellar body biogenesis and function. Biochim Biophys Acta Mol Basis of Dis. 2018; 1864(5):1609-21.

16. Velmishi V, Dervishi E, Bali D, Shehu A, Cullufi P. Constipation as an atypical sign of ARC syndrome-case report. Curr Health Sci J. 2016; 42(2):203-6.

17. Dehghani SM, Bahador A, Nikeghbalian S, Salahi H, Geramizadeh B, Malekpour A, et al. Liver transplant in a case of arthrogryposis-renal tubular dysfunction-cholestasis syndrome with severe intractable pruritus. Exp Clin Transplant. 2013; 11(3):290-2.

18. Mutlu M, Aslan Y, Aktürk-Acar F, Çakır M, Erduran E, Kalyoncu M. ARC syndrome. Turk J Pediatr. 2017; 59(4):487-90.

19. del Brío Castillo R, Squires JE, McKiernan PJ. A novel mutation in VPS33B gene causing a milder ARC syndrome phenotype with prolonged survival. JIMD Rep. 2019; 47(1):4-8.


 


 

 

Iranian Journal of Neonatology
Volume 12, Issue 2
April 2021
Pages 108-112

Files

Share

How to cite

Statistics